NO20090233L - Ny sammensetning som har affinitet for amyloid - Google Patents
Ny sammensetning som har affinitet for amyloidInfo
- Publication number
- NO20090233L NO20090233L NO20090233A NO20090233A NO20090233L NO 20090233 L NO20090233 L NO 20090233L NO 20090233 A NO20090233 A NO 20090233A NO 20090233 A NO20090233 A NO 20090233A NO 20090233 L NO20090233 L NO 20090233L
- Authority
- NO
- Norway
- Prior art keywords
- amyloid
- affinity
- salt
- carbon atoms
- substituent
- Prior art date
Links
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 231100000053 low toxicity Toxicity 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940039227 diagnostic agent Drugs 0.000 abstract 1
- 239000000032 diagnostic agent Substances 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 231100000299 mutagenicity Toxicity 0.000 abstract 1
- 230000007886 mutagenicity Effects 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000002285 radioactive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Det beskrives en forbindelse som har affinitet mot amyloid, som viser tilstrekkelig hurtig klaring fra normal vev, og som har lav toksisitet som mutagenisitet, og som har den generelle formel (1): eller et salt derav, der R1 er en gruppe valgt fra hydrogen, hydroksyl, karboksyl, sulfat, amino, nitro, cyano, en alkylsubstituent med ett til 4 karbonatomer eller en alkoksysubstituent med ett til 4 karbonatomer; R2 er en radioaktiv halogensubstituent; og m er et helt tall 0 til 2, og et lav-toksisk diagnostisk middel for Alzheimers sykdom omfattende en forbindelse representert ved formelen ovenfor eller et salt derav.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80535606P | 2006-06-21 | 2006-06-21 | |
| JP2006188034 | 2006-07-07 | ||
| PCT/JP2007/062503 WO2007148755A1 (ja) | 2006-06-21 | 2007-06-21 | 新規アミロイド親和性化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20090233L true NO20090233L (no) | 2009-02-11 |
Family
ID=38833493
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20090233A NO20090233L (no) | 2006-06-21 | 2009-01-14 | Ny sammensetning som har affinitet for amyloid |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8277777B2 (no) |
| EP (1) | EP2042501B1 (no) |
| KR (1) | KR20090025282A (no) |
| CN (1) | CN101501033B (no) |
| AU (1) | AU2007261985B2 (no) |
| CA (1) | CA2655826A1 (no) |
| IL (1) | IL196046A0 (no) |
| NO (1) | NO20090233L (no) |
| WO (1) | WO2007148755A1 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200803903A (en) | 2006-04-28 | 2008-01-16 | Nihon Mediphysics Co Ltd | Novel compound having affinity to amyloid |
| ES2376491T3 (es) | 2006-05-19 | 2012-03-14 | Nihon Medi-Physics Co., Ltd. | Compuesto que tiene afinidad por amiloide. |
| CA2670436A1 (en) | 2006-11-30 | 2008-06-05 | Nihon Medi-Physics Co., Ltd. | Novel compound having affinity for amyloid |
| EP2213672A4 (en) * | 2007-10-24 | 2012-05-02 | Nihon Mediphysics Co Ltd | NEW CONNECTION WITH AFFINITY TO AMYLOID |
| JP5313158B2 (ja) * | 2007-10-26 | 2013-10-09 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物 |
| EP2218464A1 (en) * | 2009-02-11 | 2010-08-18 | Technische Universität München | Compounds for non-invasive measurement of aggregates of amyloid peptides |
| KR101123178B1 (ko) * | 2009-04-09 | 2012-06-13 | (주)에스메디 | 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물 |
| IN2014DN00185A (no) * | 2011-06-24 | 2015-07-10 | Nihon Mediphysics Co Ltd | |
| DK2991983T3 (en) | 2013-04-29 | 2017-05-08 | Hoffmann La Roche | 2-PHENYL OR 2-HETARYLIMIDAZOLE [1,2-a] PYRIDINE DERIVATIVES |
| CN103724207B (zh) * | 2013-12-20 | 2016-07-06 | 北京智博高科生物技术有限公司 | 苯基苄基醚类衍生物及其制备方法和应用 |
| DK3197277T3 (da) * | 2014-08-29 | 2022-01-31 | Chdi Foundation Inc | Prober til billeddannelse af huntingtin-protein |
| US9926316B2 (en) * | 2016-03-03 | 2018-03-27 | The Cleveland Clinic Foundation | Antitumor derivatives for differentiation therapy |
| CN108822105A (zh) * | 2018-08-14 | 2018-11-16 | 河南师范大学 | 一种由乙苯类化合物合成2-芳基咪唑并[1,2-a]吡啶类化合物的方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4791117A (en) | 1986-09-22 | 1988-12-13 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers |
| US4871745A (en) * | 1986-09-22 | 1989-10-03 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo(1,2-A)pyridines and their use as antisecretory agents |
| US4833149A (en) | 1986-09-22 | 1989-05-23 | Ortho Pharmaceutical Corporation | 2- or 3-aryl substituted imidazo[1,2-a]pyridines |
| US4727145A (en) * | 1986-09-22 | 1988-02-23 | Ortho Pharmaceutical Corporation | 2- Or 3- aryl substituted imidazo [1,2-a]pyridines |
| NZ322674A (en) | 1995-10-17 | 1999-08-30 | Searle & Co | Method of detecting cyclooxygenase-2 |
| US6812327B1 (en) | 1996-10-25 | 2004-11-02 | Human Genome Sciences, Inc. | Neutrokine-alpha polypeptides |
| CA2340394A1 (en) | 1998-08-20 | 2000-03-02 | Jorge R. Barrio | Methods for labeling .beta.-amyloid plaques and neurofibrillary tangles |
| JP4025468B2 (ja) | 1999-07-29 | 2007-12-19 | 三井化学株式会社 | 有機電界発光素子 |
| WO2001074813A2 (en) * | 2000-03-31 | 2001-10-11 | Ortho Mcneil Pharmaceutical, Inc. | METHOD FOR USING 2- OR 3-ARYL SUBSTITUTED IMIDAZO[1,2-a] PYRIDINES AS H3 ANTAGONISTS |
| US20010051632A1 (en) | 2000-03-31 | 2001-12-13 | Wenying Chai | Phenyl-substituted indolizines and tetrahydroindolizines |
| US6908929B2 (en) | 2000-03-31 | 2005-06-21 | Ortho-Mcneil Pharmaceutical, Inc. | Phenyl-substituted imidazopyridines |
| US6514969B2 (en) | 2000-08-16 | 2003-02-04 | Boehringer Ingelheim Pharma Kg | β-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions |
| DE10040016A1 (de) | 2000-08-16 | 2002-02-28 | Boehringer Ingelheim Pharma | Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel |
| HU230581B1 (hu) | 2000-08-24 | 2017-01-30 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Tioflavin-származékok és alkalmazásuk az Alzheimer-kór diagnózisában és kezelésében |
| HUP0304083A2 (hu) | 2001-02-26 | 2004-03-29 | Bristol-Myers Squibb Pharma Company | Radiofarmakon kompozíciók, előállításuk és eljárás radiofarmakonok pufferolására |
| US6596731B2 (en) | 2001-03-27 | 2003-07-22 | Hoffmann-La Roche Inc. | Substituted imidazo[1,2-A] pyridine derivatives |
| DE60217090T2 (de) | 2001-04-23 | 2007-07-12 | The Trustees Of The University Of Pennsylvania | Amyloid plaque aggregationshemmer und diagnostische bilderzeugungsmittel |
| KR100947913B1 (ko) | 2001-08-27 | 2010-03-17 | 더 트러스티스 오브 더 유니버시티 오브 펜실바니아 | 스틸벤 유도체 및 이것을 아밀로이드 플라크의 결합 및영상화에 사용하는 용도 |
| GB0205281D0 (en) | 2002-03-06 | 2002-04-17 | Novartis Ag | Organic compounds |
| EP1356827A1 (en) | 2002-04-24 | 2003-10-29 | Mallinckrodt Inc. | Method for obtaining a 2-18F-fluor-2-deoxy-D-glucose (18F-FDG)-solution |
| AU2003242233A1 (en) | 2002-06-12 | 2003-12-31 | Bf Research Institute, Inc. | Probe compound for image diagnosis of disease with amyloid accumulation, compound for staining age spots/diffuse age spots, and remedy for disease with amyloid accumulation |
| BR0215913A (pt) | 2002-11-05 | 2005-08-09 | Ion Beam Applic Sa | Composição de radiofármacos rotulados com 18-f e processo para obtê-los |
| GB0229695D0 (en) | 2002-12-20 | 2003-01-29 | Amersham Plc | Solid-phase preparation of 18F-labelled amino acids |
| BRPI0418328A (pt) | 2003-12-31 | 2007-05-02 | Schering Plough Ltd | controle de parasitas em animais pelo uso de derivados de imidazo [1,2-b]piridazina |
| WO2007002540A2 (en) * | 2005-06-24 | 2007-01-04 | Kung Hank F | Radiolabeled-pegylation of ligands for use as imaging agents |
| US20080219922A1 (en) * | 2005-09-12 | 2008-09-11 | Goodman Mark M | Alzheimer's Disease Imaging Agents |
| ES2376491T3 (es) | 2006-05-19 | 2012-03-14 | Nihon Medi-Physics Co., Ltd. | Compuesto que tiene afinidad por amiloide. |
| EP2213672A4 (en) | 2007-10-24 | 2012-05-02 | Nihon Mediphysics Co Ltd | NEW CONNECTION WITH AFFINITY TO AMYLOID |
| JP5313158B2 (ja) | 2007-10-26 | 2013-10-09 | 日本メジフィジックス株式会社 | 新規アミロイド親和性化合物 |
| TW200922629A (en) | 2007-10-30 | 2009-06-01 | Nihon Mediphysics Co Ltd | Utilization of novel compounds with amyloid affinity and method of producing the same |
-
2007
- 2007-06-21 KR KR1020087031662A patent/KR20090025282A/ko not_active Withdrawn
- 2007-06-21 US US12/308,715 patent/US8277777B2/en active Active
- 2007-06-21 EP EP07767329.1A patent/EP2042501B1/en active Active
- 2007-06-21 WO PCT/JP2007/062503 patent/WO2007148755A1/ja not_active Ceased
- 2007-06-21 CN CN2007800298930A patent/CN101501033B/zh active Active
- 2007-06-21 AU AU2007261985A patent/AU2007261985B2/en not_active Expired - Fee Related
- 2007-06-21 CA CA002655826A patent/CA2655826A1/en not_active Abandoned
-
2008
- 2008-12-18 IL IL196046A patent/IL196046A0/en unknown
-
2009
- 2009-01-14 NO NO20090233A patent/NO20090233L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007148755A1 (ja) | 2007-12-27 |
| IL196046A0 (en) | 2009-09-01 |
| KR20090025282A (ko) | 2009-03-10 |
| AU2007261985A1 (en) | 2007-12-27 |
| AU2007261985B2 (en) | 2012-04-19 |
| US20100092387A1 (en) | 2010-04-15 |
| HK1133254A1 (en) | 2010-03-19 |
| CA2655826A1 (en) | 2007-12-27 |
| EP2042501A1 (en) | 2009-04-01 |
| EP2042501B1 (en) | 2017-04-12 |
| CN101501033B (zh) | 2012-08-01 |
| CN101501033A (zh) | 2009-08-05 |
| EP2042501A4 (en) | 2012-11-21 |
| US8277777B2 (en) | 2012-10-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20090233L (no) | Ny sammensetning som har affinitet for amyloid | |
| NO20085265L (no) | Nye forbindelser som har affinitet for amyloid | |
| WO2009054497A1 (ja) | 新規アミロイド親和性化合物 | |
| EA201070323A1 (ru) | Замещенное производное пиразола | |
| NO20084897L (no) | Ny forbindelse med affinitet til amuloid | |
| NO20074718L (no) | BCRP/ABCG2 inhibitor | |
| MY153045A (en) | Oxopyrazine derivative and herbicide | |
| NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
| WO2009054496A1 (ja) | 新規アミロイド親和性化合物 | |
| NO20065578L (no) | Substituerte metylaryl eller heteroarylamidforbindelser | |
| ATE515505T1 (de) | Heterocyclische fxr-bindende verbindungen | |
| NO20076524L (no) | Pyrazolforbindelse samt terapeutisk middel for diabetes som omfatter det samme | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| NO20073720L (no) | Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer | |
| MY158052A (en) | Indole compound | |
| HRP20130653T1 (en) | Pyrrole compounds | |
| IL198995A0 (en) | Novel compound having affinity for amyloid | |
| WO2008140099A1 (ja) | テトラゾイルオキシム誘導体および植物病害防除剤 | |
| NO20082747L (no) | Arylisoksazol-4-yl-imidazolderivater | |
| WO2008014955A3 (en) | Fungicidal compounds and compositions | |
| NO20062617L (no) | Anvendelse av glukosidase inhibitorer for terapi av mucovisidose | |
| MX2010001566A (es) | Derivado de aminopirazolamida. | |
| BRPI0606845A2 (pt) | derivados de (1,5-difenil-1h-pirazol-3-il)oxadiazol, o respectivo preparo e a respectiva aplicação em terapêutica | |
| DK1961734T3 (da) | Aminforbindelse og anvendelse deraf til medicinske formål | |
| EA200970555A1 (ru) | Трициклическое соединение и его медицинское применение |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |